Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer

Benzer Materyaller

• Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer
  Yazar:: Fujii, T., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
  Yazar:: Fujii, Takeo, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Histone deacetylase inhibitor enhances the efficacy of MEK inhibitor through NOXA-mediated MCL1 degradation in triple-negative and inflammatory breast cancer
  Yazar:: Torres-Adorno, Angie M., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer
  Yazar:: Angie M. Torres-Adorno, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without Trastuzumab
  Yazar:: Kogawa, Takahiro, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)